BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38189385)

  • 1. [ARL67156, a small-molecule CD39 inhibitor, enhances natural killer cell cytotoxicity against gastric cancer cells
    Gong Y; Aimaiti A; He Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Dec; 43(12):2006-2014. PubMed ID: 38189385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD24 targeting bi-specific antibody that simultaneously stimulates NKG2D enhances the efficacy of cancer immunotherapy.
    Han Y; Sun F; Zhang X; Wang T; Jiang J; Cai J; Gao Q; Hezam K; Liu Y; Xie J; Wang M; Zhang J
    J Cancer Res Clin Oncol; 2019 May; 145(5):1179-1190. PubMed ID: 30778749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of highly cytotoxic natural killer cells for gastric cancer.
    Mimura K; Kamiya T; Shiraishi K; Kua LF; Shabbir A; So J; Yong WP; Suzuki Y; Yoshimoto Y; Nakano T; Fujii H; Campana D; Kono K
    Int J Cancer; 2014 Sep; 135(6):1390-8. PubMed ID: 24615495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The killing effect of Tanshinol on breast cancer cells: insight into the reversion of TGF-β1-mediated suppression of NK cell functions.
    Yang C; Qian C; Zhang T; Zheng W; Zhang S; Wang S; Wang A; Zhao Y; Lu Y
    Front Biosci (Landmark Ed); 2021 Nov; 26(11):1106-1118. PubMed ID: 34856757
    [No Abstract]   [Full Text] [Related]  

  • 5. TIGIT immune checkpoint blockade enhances immunity of human peripheral blood NK cells against castration-resistant prostate cancer.
    Wang F; Liu S; Liu F; Xu T; Ma J; Liang J; Wang J; Liu D; Yang F; Li J; Xing N
    Cancer Lett; 2023 Aug; 568():216300. PubMed ID: 37414394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Blockade of TIGIT and CD39 or A2AR Enhances NK-92 Cell-Mediated Cytotoxicity in AML.
    Brauneck F; Seubert E; Wellbrock J; Schulze Zur Wiesch J; Duan Y; Magnus T; Bokemeyer C; Koch-Nolte F; Menzel S; Fiedler W
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced interaction between natural killer cells and lung cancer cells: involvement in gefitinib-mediated immunoregulation.
    He S; Yin T; Li D; Gao X; Wan Y; Ma X; Ye T; Guo F; Sun J; Lin Z; Wang Y
    J Transl Med; 2013 Aug; 11():186. PubMed ID: 23937717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelets impair natural killer cell reactivity and function in endometriosis through multiple mechanisms.
    Du Y; Liu X; Guo SW
    Hum Reprod; 2017 Apr; 32(4):794-810. PubMed ID: 28184445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trispecific killer engager 161519 enhances natural killer cell function and provides anti-tumor activity against CD19-positive cancers.
    Cheng Y; Zheng X; Wang X; Chen Y; Wei H; Sun R; Tian Z; Sun H
    Cancer Biol Med; 2020 Nov; 17(4):1026-1038. PubMed ID: 33299651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and function of killer immunologublin receptor and CD57 of natural killer cells].
    Zhao XY; Zhao XS; Wang YZ; Chang YJ; Lv M; Wang HT; Han TT; Huang XJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Feb; 46(1):115-9. PubMed ID: 24535362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interferon-α mediating the functional damage of CD56
    Zhao XG; Liu JQ; Huang HN; Lu ZM; Bai ZR; Li X; Qi JJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):975-981. PubMed ID: 38101777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rapid method for assessment of natural killer cell function after multiple receptor crosslinking.
    Al-Hubeshy ZB; Coleman A; Nelson M; Goodier MR
    J Immunol Methods; 2011 Mar; 366(1-2):52-9. PubMed ID: 21281644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity.
    Zhang C; Röder J; Scherer A; Bodden M; Pfeifer Serrahima J; Bhatti A; Waldmann A; Müller N; Oberoi P; Wels WS
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34599028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A chimeric receptor with NKG2D specificity enhances natural killer cell activation and killing of tumor cells.
    Chang YH; Connolly J; Shimasaki N; Mimura K; Kono K; Campana D
    Cancer Res; 2013 Mar; 73(6):1777-86. PubMed ID: 23302231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of Epithelial-to-mesenchymal Transition on Biological Activity of NK Cells in Esophageal Squamous Cell Carcinoma].
    Gao FX; Wu J; Ren DL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Jan; 50(1):40-47. PubMed ID: 31037903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+CD25+Foxp3+ regulatory T cells suppress NKG2D-mediated NK cell cytotoxicity in peripheral blood.
    Geng X; Li M; Cui B; Lu C; Liu X; Zhang P; Liu B; Ma C; Shen Y; Lu Z
    Medicine (Baltimore); 2019 May; 98(22):e15722. PubMed ID: 31145286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-gamma production and degranulation are differentially regulated in response to stimulation in murine natural killer cells.
    Vahlne G; Becker S; Brodin P; Johansson MH
    Scand J Immunol; 2008 Jan; 67(1):1-11. PubMed ID: 18028287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Leukocyte Antigen-G Inhibits the Anti-Tumor Effect of Natural Killer Cells via Immunoglobulin-Like Transcript 2 in Gastric Cancer.
    Wan R; Wang ZW; Li H; Peng XD; Liu GY; Ou JM; Cheng AQ
    Cell Physiol Biochem; 2017; 44(5):1828-1841. PubMed ID: 29224003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of irradiation-induced intercellular adhesion molecule-1 expression on natural killer cell-mediated cytotoxicity toward human cancer cells.
    Jeong JU; Uong TNT; Chung WK; Nam TK; Ahn SJ; Song JY; Kim SK; Shin DJ; Cho E; Kim KW; Cho D; Yoon MS
    Cytotherapy; 2018 May; 20(5):715-727. PubMed ID: 29572116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ADAM10 and ADAM17 Inhibitors on Natural Killer Cell Expansion and Antibody-dependent Cellular Cytotoxicity Against Breast Cancer Cells
    Pham DH; Kim JS; Kim SK; Shin DJ; Uong NT; Hyun H; Yoon MS; Kang SJ; Ryu YJ; Cho JS; Yoon JH; Lee JS; Cho D; Lee SH; Park MH
    Anticancer Res; 2017 Oct; 37(10):5507-5513. PubMed ID: 28982863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.